Company Overview

• Spinoff of Institut Pasteur and Institut Curie in Paris in 2020
• French and US based
• Team of 30 
• $13M funding secured
• FDA cleared, CE Mark expected Q4 2024
• 8 Patents

Technology

Medical software enabling advanced 3D and XR visualization of medical images.   Powered by real-time, lossless volume rendering and AI-driven segmentation. Available on premise and in the cloud.

Value & Market Validation

With Avatar, surgeons can bring patients' medical images to life in stunning 3D, across the treatment continuum, with a focus on the consultation room.  Leveraging Avatar Medical Vision software during patient consultations may improve patient satisfaction and reduce patient outmigration, both of which result in substantially positive healthcare economics.

Traction

• $1M customer orders in 2024
• 12 paying customers
• Medtech Strategic Partnership = 20 Hospital deployment
• 7 ongoing technology evaluations

Current Investors

France: Go Capital, Rives Croissance, CENITZ

US: Acorn Pacific Capital, Plug n Play, Corenest

Between Seed and Series A

Bridge Round $2M 

Opening Series A in H1 2025